SMARCA4 and leukemia: Exposure of cells to 10 μM inhibitor did not result in significant toxicity for any of the cell lines tested, indicating that the BRD is not important for tumor cell proliferation and survival, as also suggested by a recent study on the role of BRG1 in leukemia (26).